We integrate and summarize the current research findings on this topic, focusing on somatic mutations of the RUNX2 gene and evidence indicating RUNX2 expression levels in different tumor types as well as the RUNX2-dependent biological effects in orchestrating cancer progression. The gene discussed is RUNX2; the disease is neoplasm.